Trends of outpatient prescription drug utilization in US children, 2002-2010

Pediatrics

Volumn 130, Issue 1, 2012, Pages 23-31

  Chai, Grace ^a   Governale, Laura ^a   McMahon, Ann W ^b   Trinidad, James Phillip ^a   Staffa, Judy ^a   Murphy, Dianne ^b  

^a Center for Drug Evaluation and Research   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

ADHD; Antibiotic use; Children; Drug market; Drug safety; Frequency; Pediatric; Trends; Utilization

Indexed keywords

ACETYLSALICYLIC ACID PLUS CODEINE PHOSPHATE; AMOXICILLIN; AMPHETAMINE PLUS DEXAMPHETAMINE; AZITHROMYCIN; BUDESONIDE; CEFALEXIN; CEFDINIR; CIPROFLOXACIN PLUS DEXAMETHASONE; COTRIMOXAZOLE; FLUORIDE SODIUM; FLUTICASONE; HYDROCODONE BITARTRATE PLUS PARACETAMOL; HYDROCORTISONE; IBUPROFEN; LANSOPRAZOLE; LISDEXAMFETAMINE; METHYLPHENIDATE; MINOCYCLINE; MOMETASONE FUROATE; MONTELUKAST; NYSTATIN; PREDNISOLONE; PREDNISOLONE SODIUM PHOSPHATE; PREDNISONE; PROMETHAZINE; PSEUDOMONIC ACID; SALBUTAMOL; SERTRALINE; TRIAMCINOLONE;

ADOLESCENT; ALLERGY; ARTICLE; ASTHMA; ATTENTION DEFICIT DISORDER; CHILD; COLD; CONTRACEPTION; COUGHING; DEPRESSION; DRUG MARKETING; DRUG USE; DRUG UTILIZATION; FEMALE; HUMAN; INFANT; MALE; OFF LABEL DRUG USE; OUTPATIENT; PAIN; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SCHOOL CHILD; TREND STUDY; UNITED STATES;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION; GASTROESOPHAGEAL REFLUX; HEALTH CARE SURVEYS; HUMANS; INFANT; INFANT, NEWBORN; LEAST-SQUARES ANALYSIS; LINEAR MODELS; METHYLPHENIDATE; PHYSICIAN'S PRACTICE PATTERNS; PROTON PUMP INHIBITORS; UNITED STATES;

EID: 84863507772     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-2879     Document Type: Article

References (42)

1. Shirkey H. Therapeutic orphans. J Pediatr. 1968;72(1):119-120
2. Wilson JT. Pragmatic Assessment of Medicines Available for Young Children and Pregnant or Breast-feeding Women. Basic and Therapeutic Aspects of Perinatal Pharmacology. New York, NY: Raven Press; 1975:411-421
3. Wilson JT. An update on the therapeutic orphan. Pediatrics. 1999;104(3 pt 2):585-590 (Pubitemid 29426624)
4. Bazzano AT, Mangione-Smith R, Schonlau M, Suttorp MJ, Brook RH. Off-label prescribing to children in the United States outpatient setting. Acad Pediatr. 2009;9(2):81-88
5. Food and Drug Administration Modernization Act of 1997. Available at: www.fda.gov/RegulatoryInformation/Legislation/ FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/FDAMA/ FullTextofFDAMAlaw/default.htm. Accessed November 18, 2010
6. Best Pharmaceuticals for Children Act, January 4, 2002. Available at: www.fda.gov/RegulatoryInformation/Legislation/ FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/ucm148011. htm. Accessed November 18, 2010
7. FDAAA-Title IV: Pediatric Research Equity Act of 2007 (PREA) and Title V: Best Pharmaceuticals for Children Act 2007 (BPCA). Available at: www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/ UCM049870.pdf. Accessed November 18, 2010
8. Food and Drug Administration Amendments Act of 2007. US Public Law 110-85. Available at: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname= 110-cong-public-laws&docid=f:publ085.110.pdf. Accessed June 25, 2011
9. US Food and Drug Administration. New pediatric labeling information database. Available at: www.fda.gov/downloads/ScienceResearch/SpecialTopics/ PediatricTherapeuticsResearch/UCM163159.pdf. Accessed June 25, 2011
10. US Food and Drug Administration. Science and research, safety reporting. Available at: www.fda.gov/ScienceResearch/Special-Topics/ PediatricTherapeuticsResearch/ucm123229.htm. Accessed June 25, 2011
11. Lasky T. Estimates of pediatric medication use in the United States: current abilities and limitations. Clin Ther. 2009;31(2):436-445
12. Bloom B, Cohen RA, Freeman G. Summary health statistics for US children: National Health Interview Survey, 2010. National Center for Health Statistics. Vital Health Stat 10(250). 2011. Available at: www.cdc.gov/nchs/data/series/sr- 10/sr10-250.pdf. Accessed April 10, 2012
13. Vernacchio L, Kelly JP, Kaufman DW, Mitchell AA. Medication use among children <12 years of age in the United States: results from the Slone Survey. Pediatrics. 2009;124 (2):446-454
14. Cox ER, Halloran DR, Homan SM, Welliver S, Mager DE. Trends in the prevalence of chronic medication use in children: 2002-2005. Pediatrics. 2008;122(5). Available at: www.pediatrics.org/cgi/content/full/122/5/e1053
15. Cooper WO, Habel LA, Sox CM, et al. ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med. 2011;365(20):1896-1904
16. Kuehn BM. Stimulant use linked to sudden death in children without heart problems. JAMA. 2009;302(6):613-614
17. Greene P, Money D. DEPI/OSE, Review dated April 30, 2010. Submitted for the background package for presentation on June 10, 2010, at the Pediatric Advisory Committee Meeting, Bethesda, MD. Available at: www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/ UCM214657.pdf. Accessed April 10, 2012
18. Guidance for Industry. E11 clinical investigation of medicinal products in the pediatric population. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). December 2000. Available at: www.fda.gov/ohrms/dockets/ac/04/briefing/4028B1-07-GFI-ICH%20E11.pdf. Accessed August 10, 2011
19. National Population Census Estimates. Monthly postcensal resident population, by single year of age, sex, race, and Hispanic origin. Available at: www.census.gov/popest/data/national/asrh/2009/2009-nat-res.html. Accessed December 23, 2011
20. Rodriguez W, Selen A, Avant D, et al. Improving pediatric dosing through pediatric initiatives: What we have learned. Pediatrics. 2008;121(3):530-539
21. Iyasu S, Murphy DM. Pharmacovigilance in pediatrics. In: RD Mann and EB Andrews eds, Pharmacovigilance. 2nd ed. Chichester, United Kingdom: Wiley & Sons; 2007
22. Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005;58(4):323-337 (Pubitemid 40601980)
23. Pamer CA, Hammad TA, Wu YT, et al. Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions. Pharmacoepidemiol Drug Saf. 2010;19(2):158-174
24. Wysowski DK, Governale LA, Swann J. Trends in outpatient prescription drug use and related costs in the US: 1998-2003. Pharmacoeconomics. 2006;24(3):233-236 (Pubitemid 43374375)
25. American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics. 2004;113(5):1451-1465
26. Besser RE. Antimicrobial prescribing in the United States: good news, bad news. Ann Intern Med. 2003;138(7):605-606 (Pubitemid 38124684)
27. Lieberman JM. Appropriate antibiotic use and why it is important: the challenges of bacterial resistance. Pediatr Infect Dis J. 2003;22(12):1143-1151 (Pubitemid 37543426)
28. Dellit TH, Owens RC, McGowan JE Jr, et al Infectious Diseases Society of America; Society for Healthcare Epidemiology of America. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159-177 (Pubitemid 46084814)
29. Emmer C, Besser R. Combating antimicrobial resistance: intervention programs to promote appropriate antibiotic use. Infect Med. 2002;19:160-173 (Pubitemid 34461118)
30. Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA. 2009;302(7):758-766
31. Weissman J, Besser RE. Promoting appropriate antibiotic use for pediatric patients: a social ecological framework. Semin Pediatr Infect Dis. 2004;15(1):41-51 (Pubitemid 38620277)
32. Finkelstein JA, Stille C, Nordin J, et al. Reduction in antibiotic use among US children, 1996-2000. Pediatrics. 2003;112(3 pt 1):620-627 (Pubitemid 37082116)
33. Coco A, Vernacchio L, Horst M, Anderson A. Management of acute otitis media after publication of the 2004 AAP and AAFP clinical practice guideline. Pediatrics. 2010;125(2): 214-220
34. Schroeder K, Fahey T. Over-the-counter medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev. 2004;(4):CD001831
35. Prevacid (lansoprazole) product label, Takeda Pharmaceuticals America, Inc. Revised September 2010. Available at: www.accessdata.fda.gov/drugsatfda- docs/label/2010/020406s074,021428s021lbl.pdf. Accessed May 5, 2011
36. Lodato F, Azzaroli F, Turco L, et al. Adverse effects of proton pump inhibitors. Best Pract Res Clin Gastroenterol. 2010;24(2): 193-201
37. van der Pol RJ, Smits MJ, van Wijk MP, Omari TI, Tabbers MM, Benninga MA. Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systemic review. Pediatrics. 2011;127(5):925-935
38. Dey AN, Schiller JS, Tai DA. Summary Health Statistics for U.S. Children: National Health Interview Survey, 2002. National Center for Health Statistics. Vital Health Stat 10(221). 2004. Available at: www.cdc.gov/nchs/data/series/sr- 10/sr10-221.pdf. Accessed April 10, 2012
39. Wood JG, Crager JL, Delap CM, Heiskell KD. Beyond methylphenidate: nonstimulant medications for youth with ADHD. J Atten Disord. 2007;11(3):341-350
40. Chai G, Mehta H, Money D, Governale L. Atypical antipsychotic drug use in the US outpatient pediatric population. Presented on August 22, 2010 at: 2010 International Society for Pharmacoepidemiology's 26th International Conference on Pharmacoepidemiology and Therapeutic Risk Management; Brighton, United Kingdom
41. Centers for Disease Control and Prevention. Use of contraception and use of family planning services in the United States: 1982-2002. Centers for Disease Control and Prevention, Advance Data from Vital and Health Statistics. Number 350, December 10, 2004. Available at: www.cdc.gov/nchs/data/ad/ad350.pdf. Accessed April 10, 2012
42. Centers for Disease Control and Prevention. Teenagers in the United States: sexual activity, contraceptive use, and childbearing, National Survey of Family Growth 2006-2008. Centers for Disease Control and Prevention, National Center for Health Statistics. Series 23, Number 30, June, 2010. Available at: www.cdc.gov/nchs/data/series/sr-23/sr23-030.pdf. Accessed April 10, 2012